Bellevue Group’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202K Sell
852
-11
-1% -$2.29K ﹤0.01% 126
2026
Q1
$182K Sell
863
-6,806
-89% -$1.47M ﹤0.01% 133
2025
Q4
$1.58M Sell
7,669
-8,599
-53% -$1.62M 0.03% 103
2025
Q3
$2.55M Sell
16,268
-3,744
-19% -$578K 0.05% 92
2025
Q2
$3.36M Sell
20,012
-764
-4% -$113K 0.07% 88
2025
Q1
$2.86M Sell
20,776
-1,522
-7% -$194K 0.06% 98
2024
Q4
$2.64M Sell
22,298
-7,926
-26% -$925K 0.05% 104
2024
Q3
$3.34M Sell
30,224
-2,358
-7% -$247K 0.05% 102
2024
Q2
$3.2M Buy
32,582
+29,582
+986% +$3.01M 0.05% 103
2024
Q1
$336K Sell
3,000
-500
-14% -$53.9K 0.01% 143
2023
Q4
$353K Buy
+3,500
New +$347K 0.01% 143
2023
Q2
Sell
-10,600
Closed -$800K 159
2023
Q1
$800K Hold
10,600
0.01% 133
2022
Q4
$815K Buy
10,600
+9,682
+1,055% +$736K 0.01% 140
2022
Q3
$61K Buy
+918
New +$58.2K ﹤0.01% 166
2021
Q2
Sell
-24,000
Closed -$1.46M 216
2021
Q1
$1.46M Buy
+24,000
New +$1.32M 0.02% 150
2018
Q3
Sell
-18,000
Closed -$879K 141
2018
Q2
$879K Sell
18,000
-2,000
-10% -$113K 0.07% 122
2018
Q1
$1.25M Hold
20,000
0.12% 101
2017
Q4
$1.23M Hold
20,000
0.13% 103
2017
Q3
$1.34M Hold
20,000
0.14% 101
2017
Q2
$1.56M Hold
20,000
0.18% 90
2017
Q1
$1.63M Hold
20,000
0.22% 86
2016
Q4
$1.44M Sell
20,000
-94,280
-82% -$6.82M 0.29% 77
2016
Q3
$8.88M Sell
114,280
-74,500
-39% -$6.02M 1.6% 21
2016
Q2
$14.7M Buy
188,780
+29,150
+18% +$2.32M 2.77% 5
2016
Q1
$13.1M Buy
+159,630
New +$13M 2.37% 10

Other funds holding CAH

Bellevue Group's CAH Position: Q2 2026 in Review

Bellevue Group reduced its Cardinal Health (CAH) stake by 1.3% in Q2 2026, selling an estimated $2.29K and leaving 852 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #126.

Bellevue Group first reported a position in CAH in Q1 2016 and has held it in 25 quarters since. The position peaked at $14.7M in Q2 2016. 1,375 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Bellevue Group held 852 shares of Cardinal Health worth $202K as of Q2 2026.
  • Bellevue Group sold 11 Cardinal Health shares in Q2 2026, an estimated $2.29K.
  • Cardinal Health made up ﹤0.01% of Bellevue Group's portfolio in Q2 2026, its #126 holding.
  • Bellevue Group first reported a position in Cardinal Health in Q1 2016 and has held it in 25 quarters since.
  • Bellevue Group's Cardinal Health position peaked at $14.7M in Q2 2016.
  • 1,375 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.